We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
+13.09%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$323M
AUM Growth
+$14.5M
(+4.7%)
Cap. Flow
-$9.38M
Cap. Flow
% of AUM
-2.91%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
40
New
–
Increased
2
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$1.13M |
| 2 |
Fate Therapeutics
FATE
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$4.26M |
| 2 |
CMS Energy
CMS
|
+$2.87M |
| 3 |
Duke Energy
DUK
|
+$2.43M |
| 4 |
LVTX
LAVA Therapeutics
LVTX
|
+$689K |
| 5 |
Kodiak Sciences
KOD
|
+$377K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.27% |
| 2 | Utilities | 24.23% |
| 3 | Industrials | 19.38% |
| 4 | Financials | 9.17% |
| 5 | Consumer Staples | 5.11% |
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q3 2025 Portfolio in Review
As of Q3 2025, Bruce & Co held 40 positions worth $323M, up 4.7% from $308M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 2.5%. Bruce & Co opened no new positions and exited 1, leaving the 40-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Utilities and Industrials.
- Bruce & Co added most to LyondellBasell Industries in Q3 2025, an estimated $1.13M increase.
- Bruce & Co's biggest Q3 2025 reduction was AT&T, cutting an estimated $4.26M.
- Bruce & Co fully exited LAVA Therapeutics in Q3 2025, selling an estimated $689K.
- Bruce & Co's ten largest holdings make up 65% of its $323M portfolio in Q3 2025.
- Bruce & Co opened 0 new positions and closed 1 in Q3 2025.
- Bruce & Co's portfolio value rose 4.7% quarter-over-quarter to $323M.
Based on Bruce & Co's 13F filing for Q3 2025, filed 13 Nov 2025.